Samil Pharmaceutical Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 1,014.73 million compared to KRW 1,302.37 million a year ago. Net income was KRW 707.42 million compared to KRW 335.8 million a year ago.

Basic earnings per share from continuing operations was KRW 50 compared to KRW 24.5455 a year ago. Diluted earnings per share from continuing operations was KRW 50 compared to KRW 24.5455 a year ago. Basic earnings per share was KRW 55 compared to KRW 27 a year ago.